Amlodipine Completed Phase 1 Trials for Adverse Events / Cardiovascular Heart Disease / High Blood Pressure (Hypertension) / Drug Drug Interaction (DDI) / Healthy Volunteers / Heart Failure Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT04245046Drug-drug-interaction Study of Candesartan, Amlodipine and Atorvastatin
NCT03657550Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects
NCT03662620Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers
NCT01337674Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010)
NCT01648231Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers
NCT02075619Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions
NCT01130168The Effects of Antihypertensive Agents on Central Blood Pressure in Healthy Participants and Participants With Hypertension (MK-0000-166) (COMPLETED)
NCT01536353Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301
NCT01797926Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions
NCT01822639A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study
NCT02064556CKD-330 Drug-Drug Interaction Study (Amlodipine)
NCT02064621CKD-330 Drug-Drug Interaction Study (Candesartan)
NCT02186496Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)
NCT02548286Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs
NCT02801526Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A
NCT02811731Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B
NCT03390465Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects
NCT02962258BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed Conditions
NCT02962336Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.
NCT04262765Drug-drug-interaction Study of Ramipril, Amlodipine and Atorvastatin
NCT03912285The Pharmacokinetic Interaction Between Amlodipine and Losartan
NCT02292069Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition
NCT02295046Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition
NCT02259829Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers
NCT02259790Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers
NCT02259803Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers
NCT02259777Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Male and Female Volunteers
NCT02259816Pharmacokinetics of Telmisartan Alone and in Combination With Amlodipine in Healthy Volunteers
NCT02261064Influence of Food on the Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Japanese Male Volunteers
NCT02183675Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers
NCT02193308Bioequivalence of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers
NCT02194309Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of 40 mg Telmisartan/5 mg Amlodipine and 80 mg Telmisartan/5 mg Amlodipine in Healthy Male Volunteers
NCT02129192Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use
NCT03032315Compare the Pharmacokinetics of TAH(80/10/12.5) Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers
NCT02739672Clinical Trial to Compare the Pharmacokinetics of TAH Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers
NCT01181011Telmisartan, Amlodipine and Combination in Healthy Subjects
NCT01131923Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fasting Conditions
NCT01131936Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fed Conditions
NCT01155908Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions
NCT01155895Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions
NCT01004614Bioequivalence Study For 5 Mg Amlodipine Orally-Disintegrating Tablet
NCT01494727Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mg
NCT01735890Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet
NCT01926652Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mg